Ketamine use in the treatment of refractory status epilepticus.
about
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status EpilepticusPharmacotherapy for Status EpilepticusP2X receptors as targets for the treatment of status epilepticusMicroRNAs in the pathophysiology and treatment of status epilepticusEnhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus.Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.Refractory and super-refractory status epilepticus--an update.NMDA antagonists for refractory seizures.NMDA receptor binding in focal epilepsiesIn vivo models of cortical acquired epilepsyImmunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.Drug-induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus.Disease modification in epilepsy: from animal models to clinical applications.Combination drug therapy for the treatment of status epilepticus.Pharmacologic treatment of status epilepticus.The Future of Intensive Care Unit Sedation: A Report of Continuous Infusion Ketamine as an Alternative Sedative Agent.Recent advances in epilepsy.Intravenous ketamine for treatment of super-refractory convulsive status epilepticus with septic shock: A report of two casesBidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.Successful Use of Ketamine for Burst Suppression in Super Refractory Status Epilepticus Following Substance Abuse.Updates in Refractory Status Epilepticus.Amelioration of Pentylenetetrazole-Induced Seizures by Modulators of Sigma, N-Methyl-D-Aspartate, and Ryanodine Receptors in Mice.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
P2860
Q26746873-FCFA7CE9-C11D-42DC-B115-F643E3D322A1Q26796689-664D7CA2-B500-4F78-A179-86690D42B2E9Q26823175-9C509B94-FDD4-4A7E-8BE5-A507F568C393Q27004814-9E35B73D-644A-4D17-B369-52981B579D83Q30252723-E122CCD1-3C82-4501-AA56-6A7AEF5F55F5Q30411523-16C44E42-9B87-46DC-AB29-B9E5DBCAF716Q30807706-65CEA999-6537-46D6-B659-32CA2310670FQ35092368-34ABDC4E-F4B5-435C-8B23-CEC278BA6E06Q36150214-672F633C-BC76-4F0D-A12E-88401E052358Q36553888-CC638A89-F698-4E82-B46F-0BBBCA4AF86FQ36620651-7C32C888-E4B9-4D2C-A57F-AB2AA6A99287Q37201609-784CB928-226C-4152-83B2-7CAA55700810Q38373199-A30DB35A-4BC6-4B39-891B-E230FC718EA8Q38450069-EE97B3E2-FABD-4C67-B773-24C5B8B8B735Q38513028-3EA028E0-7BC6-4142-8E14-52B4CBD84020Q38656719-755F72C5-DEE0-4A2B-A47A-4059698CF3DFQ38872319-ED13F29E-DF5C-4D5F-9104-8D6EAC46634EQ39000942-2AEB60F3-4787-4562-BC9A-1D260B42A8AFQ40929716-0B3369AE-31BE-4ABE-9488-13290D0AA9CAQ41729281-E62619F5-3FCF-4259-BDC3-A4487A3B4155Q49753705-0692D65D-34D8-403B-86CF-48AE38791913Q54943200-E614E3BF-7423-4BC6-82E7-E3624409528AQ54966162-A8468D75-458E-4BF0-8DEA-9203E89529EDQ55535831-733A54D4-6C40-47BA-BBC0-0FC7DC1F667EQ57164876-4B374697-A3D4-4DF8-AD14-2E34E6CEBD0C
P2860
Ketamine use in the treatment of refractory status epilepticus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ketamine use in the treatment of refractory status epilepticus.
@en
type
label
Ketamine use in the treatment of refractory status epilepticus.
@en
prefLabel
Ketamine use in the treatment of refractory status epilepticus.
@en
P2093
P1433
P1476
Ketamine use in the treatment of refractory status epilepticus.
@en
P2093
Andrea S Synowiec
Carol J Schramke
Deepinder S Singh
James P Valeriano
Kevin M Kelly
Vamsi Yenugadhati
P304
P356
10.1016/J.EPLEPSYRES.2013.01.007
P577
2013-01-29T00:00:00Z